Home › NDC Lookup › Drug shortages › Felodipine Extended-Release Tablet

Felodipine Extended-Release Tablet shortage

Not a nationwide shortage — Par Health has told the FDA it is discontinuing its felodipine extended-release tablets. The FDA lists this under “To be discontinued” as of Oct 8, 2026: a company stopping its own product. 13 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.

To Be Discontinued ⚠ Supply risk: Low Cardiovascular 4 products 1 day First posted Oct 7, 2026 Updated Oct 7, 2026
Here’s the bottom line

Par Health has told the FDA it is discontinuing its felodipine extended-release tablets. Other companies (Torrent Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, A-S Medication Solutions and 10 more) still sell the same medicine and have not reported a problem.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this medicine? See what to do →
4
Affected NDCs
0/1
Reporting makers with supply
2/2
Affected strengths still listed
13
Other companies listing it
1
Days on the list
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 8, 2026 · today

Is felodipine still in shortage? — status as of Oct 8, 2026

Still listed as “To be discontinued” as of Oct 8, 2026. Par Health is stopping its own version only; 13 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.

⚠ Supply risk: Low 0 of 5 risk factors
  1. Every strength is still listed by a company — 2 of 2 strengths (2 only by other companies)
  2. More than one company still lists it — 0 of 1 reporting company with supply + 13 other companies
  3. Most affected NDCs still available — supply listed
  4. Not a long-running shortage — 1 day (a discontinuation notice, not an outage)
  5. Listed by several companies — 14 companies (1 reporting + 13 other)

A rule-based estimate of national supply risk, counting both the companies reporting the shortage and the companies listing the same medicine without a report — never your local pharmacy’s stock. How the rating works.

The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are in the green card, and the Supply-Risk rating counts them too.

Availability of affected NDCs
From the FDA shortage report
4 NDCs
To be discontinued 4
Affected strengths still listed by a company
A company on the shortage report with supply, or another company selling that strength
2/2 strengths
Still made by a company 2
Reporting companies with supply
Among the 1 company that reported this shortage — plus 13 other companies listing it, below
0/1 reporting
Reporting no supply 1
✓ Other companies listing the same medicine — not reporting a shortage
Felodipine Extended-Release Tablet listings in the current FDA NDC Directory from companies that have not filed a shortage report — these are not counted in the charts above. Some are repackagers of another company’s product. Stock can still vary by pharmacy.
Torrent Pharmaceuticals Limited Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. A-S Medication Solutions Golden State Medical Supply, Inc. Rising Pharma Holdings, Inc. Carlsbad Technology, Inc. Chartwell RX, LLC Bryant Ranch Prepack Aurobindo Pharma Limited Glenmark Pharmaceuticals Inc., USA Yiling Pharmaceutical Inc. Westminster Pharmaceuticals, LLC Proficient Rx LP
See all other options & details →
Shortage timeline
  1. Oct 7, 2026
    Currently in shortage
    4 of 4 products affected.
  2. Oct 7, 2026
    First reported to the FDA
    4 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

Which felodipine products are affected — by company

Company: Par Health, USA LLC 📞 (800) 828-9393 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Felodipine Extended-Release Tablet, 2.5 mg NDC 00603-3581-28 2.5 mg — Discontinuation in the manufacturing of the drug product —
To Be Discontinued Felodipine Extended-Release Tablet, 5 mg NDC 00603-3582-28 5 mg — Discontinuation in the manufacturing of the drug product —
To Be Discontinued Felodipine Extended-Release Tablet, 5 mg NDC 00603-3582-21 5 mg — Discontinuation in the manufacturing of the drug product —
To Be Discontinued Felodipine Extended-Release Tablet, 2.5 mg NDC 00603-3581-21 2.5 mg — Discontinuation in the manufacturing of the drug product —

These rows are company reports to the FDA for Felodipine Extended-Release Tablet — they do not cover every company that lists this medicine. A company appears here only if it told the FDA it has a supply problem, so other companies may still have stock. That’s the basis for the Where else can I get felodipine? options further down this page.

Why is Par Health discontinuing felodipine?

Additional manufacturer notes
  • Discontinuation in the manufacturing of the drug product

Based on the company-reported reason(s) and notes on file with the FDA for Felodipine Extended-Release Tablet. A drug can be short for more than one reason, and the FDA updates these as companies report changes.

What should I do if I take felodipine?

If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other companies’ versions, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Felodipine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Felodipine guide →

Where else can I get felodipine?

FDA shortages are company-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every company that lists felodipine extended-release tablets is necessarily short. Below are the other listings in the current FDA NDC Directory that are not reported in shortage: the same medicine from companies that haven’t reported a problem (the reporting company is excluded), and other dosage forms. Some listings are repackagers, which relabel another company’s product. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine from other companies (not reporting a shortage)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from companies that have not filed a shortage with the FDA:

ProductStrengthForm / routeCompanyNDC
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Torrent Pharmaceuticals Limited 13668-0132-01
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Torrent Pharmaceuticals Limited 13668-0133-01
Felodipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral Torrent Pharmaceuticals Limited 13668-0134-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0048-01
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0049-01
Felodipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0050-01
Felodipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral A-S Medication Solutions 50090-1124-00
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated, Extended Release · Oral A-S Medication Solutions 50090-5870-00
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated · Oral Golden State Medical Supply, Inc. 51407-0088-01
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated · Oral Golden State Medical Supply, Inc. 51407-0089-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated, Extended Release · Oral Rising Pharma Holdings, Inc. 57237-0108-01
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated, Extended Release · Oral Rising Pharma Holdings, Inc. 57237-0109-01
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated, Extended Release · Oral Rising Pharma Holdings, Inc. 57237-0110-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated · Oral Carlsbad Technology, Inc. 61442-0431-01
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated · Oral Carlsbad Technology, Inc. 61442-0432-01
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated · Oral Carlsbad Technology, Inc. 61442-0433-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Chartwell RX, LLC 62135-0646-90
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Chartwell RX, LLC 62135-0647-90
Felodipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral Chartwell RX, LLC 62135-0648-90
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated · Oral Bryant Ranch Prepack 63629-2016-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated · Oral Bryant Ranch Prepack 63629-2017-01
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated · Oral Bryant Ranch Prepack 63629-2018-01
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated, Extended Release · Oral Bryant Ranch Prepack 63629-2191-01
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Bryant Ranch Prepack 63629-2195-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated, Extended Release · Oral Aurobindo Pharma Limited 65862-0673-01
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated, Extended Release · Oral Aurobindo Pharma Limited 65862-0674-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated, Extended Release · Oral Glenmark Pharmaceuticals Inc., USA 68462-0233-01
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated, Extended Release · Oral Glenmark Pharmaceuticals Inc., USA 68462-0234-01
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated, Extended Release · Oral Glenmark Pharmaceuticals Inc., USA 68462-0235-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Yiling Pharmaceutical Inc. 69117-0028-01
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Yiling Pharmaceutical Inc. 69117-0029-01
Felodipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral Yiling Pharmaceutical Inc. 69117-0030-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Westminster Pharmaceuticals, LLC 69367-0264-01
Felodipine FELODIPINE 5 mg/1 Tablet, Extended Release · Oral Westminster Pharmaceuticals, LLC 69367-0265-01
Felopdipine FELODIPINE 10 mg/1 Tablet, Extended Release · Oral Westminster Pharmaceuticals, LLC 69367-0266-01
Felodipine FELODIPINE 2.5 mg/1 Tablet, Film Coated · Oral Proficient Rx LP 71205-0920-00
Felodipine FELODIPINE 5 mg/1 Tablet, Film Coated · Oral Proficient Rx LP 71205-0921-00
Felodipine FELODIPINE 10 mg/1 Tablet, Film Coated · Oral Proficient Rx LP 71205-0922-00
Felodipine FELODIPINE 2.5 mg/1 Tablet, Extended Release · Oral Bryant Ranch Prepack 72162-1158-01
Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Felodipine 5 mgNDC 00603-3582-28 Par 500 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 13668-0133-01 Torrent 100 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 23155-0049-01 Heritage 100 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 57237-0109-01 Rising 100 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 62135-0647-90 Chartwell 90 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 68462-0234-01 Glenmark 100 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 69367-0265-01 Westminster 100 tablets $0.123 AB Availability likely
Felodipine 5 mgNDC 00603-3582-21 Par 100 tablets $0.123 AB Availability likely
Felodipine 2.5 mgNDC 00603-3581-28 Par 500 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 13668-0132-01 Torrent 100 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 23155-0048-01 Heritage 100 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 57237-0108-01 Rising 100 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 62135-0646-90 Chartwell 90 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 68462-0233-01 Glenmark 100 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 69367-0264-01 Westminster 100 tablets $0.127 AB Availability likely
Felodipine 2.5 mgNDC 61442-0431-01 Carlsbad 100 tablets — AB FDA listed
Felodipine 2.5 mgNDC 63629-2017-01 Bryant 500 tablets — AB FDA listed
Felodipine 2.5 mgNDC 63629-2193-01 Bryant 100 tablets — AB Discontinued
Felodipine 2.5 mgNDC 63629-2194-01 Bryant 500 tablets — AB Discontinued
Felodipine 2.5 mgNDC 65862-0673-01 Aurobindo 100 tablets — AB FDA listed
Felodipine 2.5 mgNDC 69117-0028-01 Yiling 100 tablets — AB FDA listed
Felodipine 2.5 mgNDC 71205-0920-00 Proficient 100 tablets — AB FDA listed
Felodipine 2.5 mgNDC 72162-1158-01 Bryant 100 tablets — AB FDA listed
Felodipine 2.5 mgNDC 72162-1742-05 Bryant 500 tablets — AB FDA listed
Felodipine 2.5 mgNDC 72162-2568-01 Bryant 100 tablets — AB FDA listed
Felodipine 5 mgNDC 51407-0088-01 Golden 100 tablets — AB FDA listed
Felodipine 5 mgNDC 61442-0432-01 Carlsbad 100 tablets — AB FDA listed
Felodipine 5 mgNDC 63629-2018-01 Bryant 500 tablets — AB FDA listed
Felodipine 5 mgNDC 63629-2195-01 Bryant 100 tablets — AB FDA listed
Felodipine 5 mgNDC 63629-2196-01 Bryant 500 tablets — AB FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of felodipine — that fall in the same broad treatment class (calcium channel blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Codes & classification for pharmacists and billers
GCN Seq No 021743
GCN 02620
HICL code 006205
Ingredient (HICL) Felodipine
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A9
Therapeutic class — intermediate (HIC2) Calcium Antagonists
HIC3 code A9A
Therapeutic class — specific (HIC3) Calcium Channel Blocking Agents
AHFS code 24:28.08.00
AHFS class Dihydropyridines
FDB label name FELODIPINE ER 2.5 MG TABLET
FDB brand name Felodipine Er
Legend status F — Federal legend — prescription drug or device
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Felodipine shortage FAQs

Is felodipine still in shortage?
Not as a nationwide shortage — the FDA lists felodipine extended-release tablets under “To be discontinued” as of Oct 8, 2026: Par Health has told the FDA it is stopping its own product, while 13 other companies still sell the same medicine and have not reported a problem.
Which strengths of felodipine are affected?
The FDA record covers 2 strengths: 2.5 mg, 5 mg. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Which felodipine products are affected?
Felodipine Extended-Release Tablet, 2.5 mg (NDC 00603-3581-28); Felodipine Extended-Release Tablet, 5 mg (NDC 00603-3582-28); Felodipine Extended-Release Tablet, 5 mg (NDC 00603-3582-21) and 1 more. The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will felodipine be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Torrent Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, A-S Medication Solutions and 10 more, so ask your pharmacy to order another company’s version.
Can I still get felodipine somewhere?
Other companies (Torrent Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals, A-S Medication Solutions and 10 more) sell the same medicine and have not reported a problem. See “Where else can I get felodipine?” above — stock still varies by pharmacy.
What should I do if I take felodipine?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the felodipine shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (0–2)Several companies still list it and most strengths or pack sizes are still listed by someone — counting both the companies reporting the shortage and the companies listing the same medicine without a report. A listing is not a stock check.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes without a source, or a long-running outage. A company’s discontinuation notice is not an outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (companies listing the same ingredient & form — the "other companies" the rating counts); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages